|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> 精氨酸酶抑制剂1>> 市场分析报告 |
精氨酸酶抑制剂1市场分析报告 |
|
Cystic Fibrosis - Pipeline Insight, 2022 ... CB-280 is a potent and selective oral inhibitor of arginase. Arginase plays an important role in the pathophysiology ... from patients with CF has elevated arginase activity leading to diminished arginine levels ... Report Package Immuno-Oncology: Inhibitory and Stimulatory Immunomodulators ... Analysis: PD-1 and PD-L1 Immune Checkpoint Inhibitors 2018 Competitor Analysis: CTLA-4, LAG ... -3, TIGIT & Other Immune Checkpoint Inhibitors 2018 Competitor Analysis: CD40, ... of INterferon Genes) Receptor Others (e.g. arginase) More than 190 unique molecules ... Competitor Analysis: Inhibitory and Stimulatory Immunomodulators in Immuno-Oncology ... : PD-1 and PD-L1 Immune Checkpoint Inhibitors 2016 Competitor Analysis: Inhibitors of Negative Immune Checkpoints CTLA ... (STimulator of INterferon Genes) Receptor Others (e.g. arginase) More than 90 unique molecules (mostly ... Competitor Analysis: Tumor Microenvironment Modulation via IDO, TGF-?/R, CXCR4, CSF-1R, CD47-SIRP?, Adenosine, STING & Others ... 2016 the competitive field of mainly inhibitors and antagonists of substrates, enzymes and ... (STimulator of INterferon Genes) Receptor Others (e.g. arginase) Purchase of the pdf report includes ... Competitor Analysis: Tumor Microenvironment Modulation via IDO, TGF-?, CXCR4, CSF-1R, CD47-SIRP?, adenosine pathway & STING 2018 Competitor Analysis: Tumor Microenvironment Modulation via IDO, TGF-?, CXCR4, CSF-1R, CD47-SIRP?, adenosine pathway & STING 2018 This Competitive Intelligence report analyzes the competitive field of modulators of the tumor microenvironment via IDO & TDO, ... |